Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03041051
Other study ID # 51198eAS
Secondary ID
Status Active, not recruiting
Phase Phase 4
First received February 1, 2017
Last updated February 1, 2017
Start date December 2015
Est. completion date March 2017

Study information

Verified date February 2017
Source Aghia Sophia Children's Hospital of Athens
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of a combined vaccination schedule of the 13-valent pneumococcal conjugate (PCV13) and 23valent plain polysaccharide vaccine (PPV23) on the establishment of immunological memory in HIV-infected adults on ART.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date March 2017
Est. primary completion date March 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- CD4 T cell count >200cells/µl

- on ART

Exclusion Criteria:

- no previously recorded allergy to PCV, PPV23

- no intravenous immunoglobulin (IVIG) given within the previous 6 months

- no other vaccine given within the previous 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
PCV13

PPV23


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Aghia Sophia Children's Hospital of Athens

Outcome

Type Measure Description Time frame Safety issue
Primary immunoglobulin G (IgG) B memory cell response one month post vaccination (measured by flow cytometry) immunoglobulin G (IgG) B memory cell response one month post vaccination (measured by flow cytometry) One month post-PCV13, PPV23
Primary immunoglobulin M (IgM) B memory cell response one month post vaccination (measured by flow cytometry) immunoglobulin M (IgM) B memory cell response one month post vaccination (measured by flow cytometry) One month post-PCV13, PPV23
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02135419 - Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions Phase 3
Active, not recruiting NCT02663856 - My Smart Age With HIV: Smartphone Self-assessment of Frailty
Completed NCT02663869 - Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Completed NCT02846402 - Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda N/A
Completed NCT02921516 - Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings N/A
Completed NCT02659306 - Metformin Immunotherapy in HIV Infection Phase 1
Completed NCT02564341 - Targeting Effective Analgesia in Clinics for HIV - Intervention N/A
Active, not recruiting NCT02302950 - A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas N/A
Terminated NCT02109224 - Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection Phase 1
Terminated NCT01902186 - Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir Phase 4
Completed NCT01830595 - Lactoferrin Treatment in HIV Patients Phase 2
Completed NCT01852942 - Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV Phase 2
Completed NCT02269605 - Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment Phase 1
Completed NCT01946217 - Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials N/A
Completed NCT02527135 - Text Messaging to Improve HIV Testing Among Young Women in Kenya N/A
Completed NCT02525146 - Birmingham Access to Care Study N/A
Completed NCT02118168 - Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002 N/A
Active, not recruiting NCT02602418 - Neural Correlates of Working Memory Training for HIV Patients N/A
Completed NCT01805427 - Antiretroviral Therapy and Extreme Weight N/A